Searchable abstracts of presentations at key conferences in endocrinology

ea0063gp71 | Thyroid Autoimmune Disorders | ECE2019

The randomised probiotic trial of indigo study (investigation of novel biomarkers and definition of role of the microbiome in Graves’ orbitopathy)

Salvi Mario , Colucci Giuseppe , Masetti Giulia , Covelli Danila , Muller Ilaria , Koehling Hedda , Garaiova Iveta , Michael Daryn , Zhang Lei , Ludgate Marian , Marchesi Julian , Biscarini Filippo

Background: Changes of the gut microbiota may impact on the mechanisms of immune tolerance in GravesÂ’ disease (GD) and GravesÂ’ orbitopathy (GO). Probiotics, which contain live micro-organisms, can modify the composition of the gut microbiota.Aims: We tested in a double-blind randomized placebo controlled trial whether the administration of a well-characterized, commercially available, probiotic would 1) modify the microbiota composition in GD/G...

ea0041ep3 | Adrenal cortex (to include Cushing's) | ECE2016

Pro-coagulant imbalance in patients with Cushing disease detected by thrombin generation assay is associated with increased levels of neutrophil extracellular trap-related factors

Verrua Elisa , Sala Elisa , Malchiodi Elena , Ferrante Emanuele , Arnaldi Giorgio , Trementino Laura , Tripodi Armando , Semeraro Fabrizio , Ammollo Concetta T , Colucci Mario , Padovan Lidia , Chantarangkul Veena , Peyvandi Flora , Mantovani Giovanna

Patients with Cushing disease (CD) are at increased risk of venous thromboembolism (VTE). It was surmised, but not conclusively shown that the risk is related to plasma hypercoagulability secondary to the effect of glucocorticoids. This study aimed at investigating the thrombin-forming potential of patients with CD in the presence of a functioning protein C system by adding its main physiological activator, thrombomodulin. Under these experimental conditions, which mimic close...